Analysis: Pipeline of biotech crop research said to slow as field trials continue

08/22/2005 | Hindu Business Line (India), The

A news report maintains the pipeline for biotech crop research may be slowing down, with the USDA reporting a decline in field trials since 1995 leading to the current situation in which no petition has been filed this year for a field trial in the U.S. Monsanto, DuPont and Syngenta have been active in conducting trials on biotech crops, but the writer speculates that a lengthening approval process by the FDA could be one possible cause of the slowdown.

View Full Article in:

Hindu Business Line (India), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
Boise, ID